China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Related Insights
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Podcast
Why Rare Disease Therapeutics Need Early Market Access Planning
Jan 4, 2023
Blog
Rachel Smith joins Parexel as Executive Director and Head of the Rare Disease, Center of Excellence
Aug 10, 2022
Whitepaper
Reimbursement framework for medical devices in India
Mar 7, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Article
EU Orphan Drug Designation – overcoming regulatory challenges
Jul 20, 2022